The early phase of the COVID-19 epidemic in Lombardy, Italy.

COVID-19 Coronavirus Epidemiology Lombardy outbreak Reproduction number SARS-CoV-2 Transmission dynamics

Journal

Epidemics
ISSN: 1878-0067
Titre abrégé: Epidemics
Pays: Netherlands
ID NLM: 101484711

Informations de publication

Date de publication:
12 2021
Historique:
received: 02 03 2021
revised: 11 10 2021
accepted: 12 11 2021
pubmed: 24 11 2021
medline: 21 12 2021
entrez: 23 11 2021
Statut: ppublish

Résumé

In the night of February 20, 2020, the first epidemic of the novel coronavirus disease (COVID-19) outside Asia was uncovered by the identification of its first patient in Lombardy region, Italy. In the following weeks, Lombardy experienced a sudden increase in the number of ascertained infections and strict measures were imposed to contain the epidemic spread. We analyzed official records of cases occurred in Lombardy to characterize the epidemiology of SARS-CoV-2 during the early phase of the outbreak. A line list of laboratory-confirmed cases was set up and later retrospectively consolidated, using standardized interviews to ascertained cases and their close contacts. We provide estimates of the serial interval, of the basic reproduction number, and of the temporal variation of the net reproduction number of SARS-CoV-2. Epidemiological investigations detected over 500 cases (median age: 69, IQR: 57-78) before the first COVID-19 diagnosed patient (February 20, 2020), and suggested that SARS-CoV-2 was already circulating in at least 222 out of 1506 (14.7%) municipalities with sustained transmission across all the Lombardy provinces. We estimated the mean serial interval to be 6.6 days (95% CrI, 0.7-19). Our estimates of the basic reproduction number range from 2.6 in Pavia (95% CI, 2.1-3.2) to 3.3 in Milan (95% CI, 2.9-3.8). A decreasing trend in the net reproduction number was observed following the detection of the first case. At the time of first case notification, COVID-19 was already widespread in the entire Lombardy region. This may explain the large number of critical cases experienced by this region in a very short timeframe. The slight decrease of the reproduction number observed in the early days after February 20, 2020 might be due to increased population awareness and early interventions implemented before the regional lockdown imposed on March 8, 2020.

Sections du résumé

BACKGROUND
In the night of February 20, 2020, the first epidemic of the novel coronavirus disease (COVID-19) outside Asia was uncovered by the identification of its first patient in Lombardy region, Italy. In the following weeks, Lombardy experienced a sudden increase in the number of ascertained infections and strict measures were imposed to contain the epidemic spread.
METHODS
We analyzed official records of cases occurred in Lombardy to characterize the epidemiology of SARS-CoV-2 during the early phase of the outbreak. A line list of laboratory-confirmed cases was set up and later retrospectively consolidated, using standardized interviews to ascertained cases and their close contacts. We provide estimates of the serial interval, of the basic reproduction number, and of the temporal variation of the net reproduction number of SARS-CoV-2.
RESULTS
Epidemiological investigations detected over 500 cases (median age: 69, IQR: 57-78) before the first COVID-19 diagnosed patient (February 20, 2020), and suggested that SARS-CoV-2 was already circulating in at least 222 out of 1506 (14.7%) municipalities with sustained transmission across all the Lombardy provinces. We estimated the mean serial interval to be 6.6 days (95% CrI, 0.7-19). Our estimates of the basic reproduction number range from 2.6 in Pavia (95% CI, 2.1-3.2) to 3.3 in Milan (95% CI, 2.9-3.8). A decreasing trend in the net reproduction number was observed following the detection of the first case.
CONCLUSIONS
At the time of first case notification, COVID-19 was already widespread in the entire Lombardy region. This may explain the large number of critical cases experienced by this region in a very short timeframe. The slight decrease of the reproduction number observed in the early days after February 20, 2020 might be due to increased population awareness and early interventions implemented before the regional lockdown imposed on March 8, 2020.

Identifiants

pubmed: 34814093
pii: S1755-4365(21)00072-4
doi: 10.1016/j.epidem.2021.100528
pmc: PMC8605863
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100528

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Danilo Cereda (D)

Directorate General for Health, Lombardy Region, Milano, Italy.

Mattia Manica (M)

Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.

Marcello Tirani (M)

Directorate General for Health, Lombardy Region, Milano, Italy; Health Protection Agency of the Metropolitan Area of Milan, Milano, Italy. Electronic address: marcello_tirani@regione.lombardia.it.

Francesca Rovida (F)

Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia, Pavia, Italy.

Vittorio Demicheli (V)

Health Protection Agency of the Metropolitan Area of Milan, Milano, Italy.

Marco Ajelli (M)

Laboratory for Computational Epidemiology and Public Health, Indiana University School of Public Health, Bloomington, United States.

Piero Poletti (P)

Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.

Filippo Trentini (F)

Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy; Carlo F. Dondena Centre for Research on Social Dynamics and Public Policy, and CovidCrisisLab, Bocconi University, Milano, Italy.

Giorgio Guzzetta (G)

Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.

Valentina Marziano (V)

Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.

Raffaella Piccarreta (R)

Carlo F. Dondena Centre for Research on Social Dynamics and Public Policy, and CovidCrisisLab, Bocconi University, Milano, Italy; Department of Decision Sciences, Bocconi University, Milan, Italy.

Antonio Barone (A)

Regional Agency for Innovation and Procurement, Milano, Italy.

Michele Magoni (M)

Epidemiology Unit, Health Protection Agency of Brescia, Brescia, Italy.

Silvia Deandrea (S)

Department of Hygiene and Preventive Medicine, Health Protection Agency of Pavia, Pavia, Italy.

Giulio Diurno (G)

Directorate General for Health, Lombardy Region, Milano, Italy.

Massimo Lombardo (M)

ASST Lodi, Lodi, Italy.

Marino Faccini (M)

Health Protection Agency of the Metropolitan Area of Milan, Milano, Italy.

Angelo Pan (A)

Infectious Diseases Unit, ASST di Cremona, Cremona, Italy.

Raffaele Bruno (R)

Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia, Pavia, Italy; Infectious Diseases Unit, Fondazione IRCCS Policlinico San Matteo, Italy.

Elena Pariani (E)

Department of Biomedical Sciences for Health, University of Milan, Milano, Italy.

Giacomo Grasselli (G)

Department of Pathophysiology and Transplantation, University of Milan, Milano, Italy; Department of Anesthesia, Intensive Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Alessandra Piatti (A)

Directorate General for Health, Lombardy Region, Milano, Italy.

Maria Gramegna (M)

Directorate General for Health, Lombardy Region, Milano, Italy.

Fausto Baldanti (F)

Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia, Pavia, Italy.

Alessia Melegaro (A)

Carlo F. Dondena Centre for Research on Social Dynamics and Public Policy, and CovidCrisisLab, Bocconi University, Milano, Italy; Department of Social and Political Sciences, Bocconi University, Milano, Italy.

Stefano Merler (S)

Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy. Electronic address: merler@fbk.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH